C7A.093 – Malignant carcinoid tumor of the kidney

ICD-10-CM 2027 diagnosis code · Malignant neuroendocrine tumors (C7A)

Billable code

ICD-10-CM code C7A.093

Code: C7A.093 (claims format: C7A093)
Description: Malignant carcinoid tumor of the kidney
Billable: Yes – valid for HIPAA-covered transactions
Valid for: Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter: 2. Neoplasms (C00-D49)
Block: C7A Malignant neuroendocrine tumors (C7A)
Parent codes: C7A › C7A.0 › C7A.09

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

C7A – Malignant neuroendocrine tumors

Excludes2 (not included here):

malignant pancreatic islet cell tumors (C25.4)
Merkel cell carcinoma (C4A.-)

Use additional code:

code to identify any associated endocrine syndrome, such as:
carcinoid syndrome (E34.00)

Code also:

any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Index terms for C7A.093

Entries in the ICD-10-CM alphabetic index that lead to this code:

Tumor, carcinoid, malignant, kidney

Related codes in C7A.09

Frequently asked questions

What is ICD-10 code C7A.093?

C7A.093 is the ICD-10-CM code for malignant carcinoid tumor of the kidney, in the block C7A (Malignant neuroendocrine tumors (C7A)).

Is C7A.093 a billable code?

Yes. C7A.093 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does C7A.093 belong to?

It belongs to category C7A – Malignant neuroendocrine tumors.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.